These tips are probably more applicable to a university tech
transfer situation rather than a research company.
1.
Internet searches using search engines (e.g.
Google) and PubMed and can be effective for identifying relevant prior art for
many areas of biotech. Such searches will cost little and can quickly give a
good picture of the prior art.
2.
As a preliminary point it may be worth assessing
whether the invention is ground-breaking or whether it a development of earlier
work. Inventions which represent
‘follow-on’ work can of course be valuable, but may be more likely to be
objected to as being obvious. Patent
application based on follow-on work might have narrow claims.
3.
Some analysis of commercial worth is usually
essential. This will be an important
factor in choosing whether or not to file.
Commercial worth can of course be complex to assess. It can be based on the value of sales of the
produce or factors such as whether the patent application will be an important
part of a collaboration agreement.
4. Make sure you are aware of all possible
inventors and all parties that may have rights in the application. All contributions from external people should
be looked at carefully as well as confidential information and materials they
might have provided.
5.
Inventive step (obviousness) is often the most
important issue for patentability. All
surprising advantages and unexpected effects should be identified and assessed.
6.
At many patent offices biotech Examiners are very
good at spotting what is obvious.
Inventions that arise from routine experimentation will be challenged. Thus one must take into account variations of
the invention that would be obvious in the relevant field, such as combining
the drug with other agents for the same conditions or delivering in the same
way.
7.
The initial view of what the invention is may
change once a patent attorney provides comments on patentability. This can help focus the scientists’ minds on
what the actual contribution is. Scientists can be too optimistic or too
negative about their own work, and will often find it difficult to assess
patentability.
8.
It can be useful to probe the scientists for
their reasons for doing the work that they did.
This can provide insights which might not be easy to see when simply
comparing the invention to the prior art, and might help in the way the
invention is presented in the patent application.
9.
Ascertain the relationship between the invention
and all relevant work being done by the group.
That will assist the understanding of how the invention fits into the
research as a whole, as well as providing information about work to be done in
the priority year and work which may lead to future filings.
10.
Bear in mind that obscure publications or publications
with unsubstantiated disclosure can still be problematic prior art, though such
papers might be dismissed by the scientists.
You may also wish to see related articles Patent Advice for Research Companies and How is Biotech Patenting Different
You may also wish to see related articles Patent Advice for Research Companies and How is Biotech Patenting Different
No comments:
Post a Comment